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A B S T R A C T   
Hypothermia is a widely used clinical practice for neuroprotection and is a well-established method to mitigate 
the adverse effects of some clinical conditions such as reperfusion injury after cardiac arrest and hypoxic 
ischemic encephalopathy in newborns. The discovery, that lowering the core temperature has a therapeutic 
potential dates back to the early 20th century, but the underlying mechanisms are actively researched, even 
today. Especially, in the area of neural disorders such as epilepsy and traumatic brain injury, cooling has 
promising prospects. It is well documented in animal models, that the application of focal brain cooling can 
effectively terminate epileptic discharges. There is, however, limited data regarding human clinical trials. In this 
review article, we will discuss the main aspects of therapeutic hypothermia focusing on its use in treating epi-
lepsy. The various experimental approaches and device concepts for focal brain cooling are presented and their 
potential for controlling and suppressing seizure activity are compared.   
1. Characteristics of epilepsy 
Epilepsy is a heterogeneous group of chronic neurological disorders 
that are characterized by recurrent unprovoked seizures. Epileptic sei-
zures occur when neurons are intermittently activated in an abnormally 
excessive and highly synchronous manner. Focal and generalized sei-
zures are distinguished according to the localization of activated neu-
rons. The onset of a focal seizure is limited to a part of one hemisphere, 
during generalized seizures, the initial activation of neurons happen 
throughout both hemispheres [1]. 
Interictal - meaning between seizures - epileptiform activity can also 
occur in epilepsy patients. It takes the form of epileptiform discharges 
(EDs), which are simply transients with a characteristic spiky 
morphology. EDs are important in the diagnosis of epilepsy [2]. 
Primarily, epilepsy is treated with pharmacological interventions 
such as administration of antiepileptic drugs (AEDs, but even the best 
medications cannot control the seizures of over 30 % of epilepsy pa-
tients. These patients are considered to have refractory epilepsy (SE) [3]. 
Surgical resection can only be performed if the epileptogenic foci are 
not located in eloquent areas such as the motor and speech cortices, and 
is not always successful [4]. 
One potential evidence based alternative to AEDs and surgical 
resection is neuromodulation by focal stimulation in the central nervous 
system, like the anterior thalamus deep brain stimulation [5] or stimu-
lation of the vagus nerve on the neck [6]. 
The third option would be the application of focal brain cooling in 
cases of focal epilepsies where the epileptogenic zone is in an eloquent 
area. Numerous animal studies show the efficacy of focal cooling in 
terminating ongoing seizures, reducing seizure frequency and the 
amplitude of epileptic discharges [7]. Human trials with the use of 
therapeutic hypothermia were also conducted, investigating its benefi-
cial effects on other disorders as well, such as traumatic brain injury [8] 
or ischemic stroke [9]. 
2. Historical background of therapeutic hypothermia 
The earliest descriptions on the use of therapeutic hypothermia date 
back to the late 19th century. By the 1870s, researchers concluded, that 
local hypothermia could reduce neurologic functions at a systemic level. 
At this time, only global conclusions were drawn without any insight 
regarding the cellular mechanisms underlying hypothermia [10]. 
The potential clinical use of cooling has been discussed since the 
1940s. In 1959, Fay suggested that implanting a metal capsule, through 
which chilled fluid is circulated, has promising effects in treating head 
* Corresponding author. 
E-mail address: fekete.zoltan@itk.ppke.hu (Z. Fekete).  
Contents lists available at ScienceDirect 
Seizure: European Journal of Epilepsy 
journal homepage: www.elsevier.com/locate/seizure 
https://doi.org/10.1016/j.seizure.2020.09.018 
Received 21 April 2020; Received in revised form 15 September 2020; Accepted 21 September 2020   
Seizure: European Journal of Epilepsy 82 (2020) 80–90
81
trauma [10]. Baldwin was the first to demonstrate that systemic hypo-
thermia can suppress EDs in the epileptic primate brain [11]. 
It was reported in 1969 that grand mal seizures stop when rectal 
temperature reaches 36 ◦C in human patients with epilepsy. Also, focal 
cooling in cats below 26.9 ◦C terminated penicillin G induced seizures in 
the visual area, which reappeared after rewarming [12]. 
Sourek and colleagues used a device called the Autohypotherm for 
general hypothermia combined with local extravascular irrigation with 
iced saline in their 1970 study. Core temperatures of human patients 
could be dropped below 30 ◦C, while final local brain temperature 
dropped below 24 ◦C in 21 patients and below 20 ◦C in 10 patients. They 
were also able to measure the temperature gradient in the brain tissue 
during irrigation: the temperature of deeper structures were always 
higher than that of the surface and rose about 2 ◦C for each additional 10 
mm of depth. During a 1 year post-surgery period, seizures were reduced 
or completely eliminated in 60 % of the patients [13]. 
Focal cooling was intensely researched in the 1960s and 1970s, but 
later the interest in the field dropped. The number of published studies 
rose again in the late 1990 and early 2000s and since then it has 
remained an area of active research. 
An important observation was in the 1980s that the mild to moderate 
range (reducing brain temperature to 31 ◦C–35 ◦C) yielded the best re-
sults in terms of neuroprotection [14]. 
Insights gained through experiments with acutely perfused brain 
slice preparations carried out from the 1980s up until today further 
confirmed the neuroprotective functions of lowered temperature: 
excessive release of acetylcholine [15] and ischemia-induced release of 
monoamines are decreased by hypothermia [16]. Anticonvulsant effect 
of cooling is apparent as it is able to terminate seizure-like activity in 
rodent slices within seconds [17] 
Nowadays, therapeutic hypothermia is one of the most important 
methods of neuroprotection: cooling the body to 32–35 ◦C improves 
neurological outcome in scenarios such as post-cardiac arrest [18], 
traumatic brain injury [19], spinal cord injury [20] and controlled 
temporary arterial ligation during microsurgical neurovascular in-
terventions [21] 
3. Physiological effects of hypothermia and its use in treating 
epilepsy 
Hypothermia causes reduced neurologic functions through a variety 
of mechanisms: rapid reduction in neurotransmitter release [22], 
alternation of kinetics in voltage-gated ion channels, decreased cerebral 
metabolism and reversible disruption of the network synchrony [23]. 
Other important ways in which hypothermia affects central neuronal 
excitability include increased input resistance, reduced synaptic trans-
mission, decreased amplitude in population spikes and an increased 
spike duration [24–26]. 
The evoked potential of the cat somatosensory cortex is recognizably 
changed by focal cooling: irrigating the cortex with iced fluid for 30 s 
caused the complete disappearance of evoked waves, the alterations 
depended not only on the degree, but also on the rate of cooling [27]. 
Cooling the rat visual cortex from 35 ◦C to 7 ◦C increased input resis-
tance and decreased K+ conductance, but had no effect on Na2+ current 
or its activation threshold [28]. The glutamate binding affinity of neu-
rons is significantly affected by temperature change, and the speed of 
diffusion may also be altered [29]. Even structural changes of the ce-
rebral cortex can occur: the density of synaptic terminals and the 
number of microtubuli in the preterminal axon both increased in 
response to cooling to 8− 10 ◦C [30]. All these changes are reversible and 
normal neurologic functions are restored upon warming up [31]. 
Therapeutic hypothermia has anti-inflammatory, anti-apoptotic and 
anti-epileptic effects as well. The beneficial effects of hypothermia may 
affect pathophysiologic cascades initiated by brain injuries, that can 
cause edema, seizures, and apoptosis [23]. The neuroprotective conse-
quences of cooling are summarized in Table 1. 
3.1. Epilepsy treatment with hypothermia 
There are several possible mechanisms suggested by which focal 
cooling exerts its antiepileptic effects, however, the exact mechanisms 
are poorly characterized. Some of the mechanisms are reduction in 
neurotransmitter release, alternation of activation-inactivation kinetics 
in voltage-gated ion channels, and slowing of catabolic processes [4]. 
Evoked synaptic activity and synchronized spontaneous epileptiform 
activity are both affected by hypothermia. Ion channels possess a key 
role in synaptic transmission and epileptiform discharges suggesting 
that hypothermia could affect ion channel gating properties [3]. 
Effects of hypothermia on epileptic brain activities are extensively 
researched in animal models. Injection of kainate into specific areas of 
the brain is a common way to induce spontaneous epileptic seizures in 
animals. 
Kainic acid-induced seizures in rats treated with hypothermia at core 
temperatures of 28 ◦C reduced ictal discharges by 50 %. Reaching a core 
temperature of 23 ◦C by further cooling almost completely eliminated 
the epileptiform discharges, without any hippocampal cell loss. On the 
other hand, animals treated with 42 ◦C hyperthermia had significant cell 
loss, and died within 2 h after severe tonic seizures [32]. Cooling to 30 
◦C can result in longer latency, shorter duration, and less frequent sei-
zures even when it is applied before a kainate injection [33]. Nitric oxide 
production and hippocampal cell loss were both reduced during kainate 
induced seizures in immature rabbits [34]. Beside reducing seizures, 
cooling can also decrease brain edema and improve cognitive functions 
[35]. 
Table 1 
Physiological effects of hypothermia (based on [36]).  
Condition, process Neuroprotective effect of hypothermia Reference 
Ischemia 
Reduced extracellular levels of 
excitatory neurotransmitters 
[37] 
Decreased brain glycine levels [38] 
Decreased release of monoamines and 
their toxic metabolites into the 
extracellular space 
[16] 
Increased levels of BDNF and other 
neurotrophins 
[39] 
Reduced proliferation, migration, 




Decreased p53 protein levels in the 
brain [41] 
Altered levels of proteins Bcl-2 and 
cytochrome C 
[42] 
Blocked TNF pathway of apoptosis [43] 
Stress-activated signaling pathways are 
affected avoiding cell apoptosis 
[44] 
Apoptosis is prevented by inhibiting the 
caspase pathway [45] 
Blocked proteins responsible for 
mediating the caspase-independent 
apoptosis 
[46] 
Blocked delta-PKC after ischemia [47] 
Reinforced Akt pathway and structural 
alterations in PTEN 
[48] 





Lowered lactate levels from anaerobic 
metabolism [50] 
Decreased concentrations of 
thromboxane A2 
[51] 
Reduced free radical levels after 
neuronal damage 
[52] 
Decreased production of inflammatory 
cytokines [53] 
Reduced disruption of the blood–brain 
barrier 
[54] 
Suppressed epileptogenic electrical 
activity 
[55]  
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In animals, hypothermia may be achieved by forced swimming in 
cold water. Rats with lithium-pilocaprine seizures forced to swim for at 
least 5 min in 20 ◦C showed anticonvulsant and neuroprotective effects 
of lowered temperature, including a significantly reduced hippocampal 
cell loss compared to controls. No tolerance was developed even after 
repeated swimming [56]. 
In human patients with intractable epilepsy, focal brain cooling 
affected glutamate and GABA concentrations, cerebral blood flow and 
glucose metabolism. Nomura et al. induced focal cooling limited to the 
epileptogenic zone, where brain temperature immediately reached 15 
◦C and was maintained at this temperature for 30 min. Cooling reduced 
amplitude of ECoG and cerebral blood flow was significantly decreased. 
Extracellular glutamate was significantly reduced to 51.2 %, while 
cortical GABA levels were reduced to 35.1 % of control levels during 
brain cooling; however this reduction did not correlate with the 
reduction in ECoG and was not significant. Glycerol and lactate levels 
decreased during cooling, while glucose and pyruvate levels were 
maintained throughout the procedure. After cooling was stopped, brain 
temperature returned to normal within 30 min. No patients experienced 
adverse effects relevant to the measurements [57,58]. 
4. Approaches to cooling the body and brain 
General hypothermia or systemic cooling refers to cooling the whole 
organism to a target temperature by means of a cooling chamber or ice 
bath. With this method mild to moderate hypothermia can be induced. It 
was applied mostly in early human trials, but for certain clinical con-
ditions such as ischemia or post cardiac arrest, it is still in use today. 
Focal cooling offers more specificity to cool the brain than general 
hypothermia. A cooling helmet or cap is a noninvasive approach, besides 
that, several practices exist for the invasive cooling of the brain. Invasive 
focal cooling methods offer the greatest temperature reduction. Some 
invasive techniques utilize a special device for the purpose of cooling. 
Among the various methods of local hypothermia, the simplest and 
most prevalent in clinical scenarios is epidural, subdural or subarach-
noid irrigation of the brain with cold saline [59]. 
The most commonly used cooling device in vitro and in vivo studies is 
the Peltier chip [60]. Another common way of inducing local hypo-
thermia is placing a device of plastic or metal tubing in contact with the 
brain, through which chilled fluid is circulated. Table 2 shows the 
various cooling methods used in animal models and human patients 
with typical cooling ranges. 
4.1. General hypothermia 
General hypothermia means that the whole organism is cooled to a 
specific temperature to mitigate local adverse effects of diseases. The 
degrees of cooling have been previously classified as mild (34–35.9 ◦C), 
moderate (32–33.9 ◦C), moderate-deep (30–31.9 ◦C), and deep (<30 ◦C) 
hypothermia [14]. 
General hypothermia is becoming a standard practice for adults 
resuscitated after cardiac arrest and for infants treated for perinatal 
hypoxic ischemic encephalopathy. In these cases, core body temperature 
is usually lowered to 32–35 ◦C meaning a state of moderate hypother-
mia. Systemic hypothermia showed beneficial effects in neonates diag-
nosed with perinatal stroke and encephalopathy. Seizures did not 
develop in neonates treated with hypothermia, while the untreated ones 
had seizures and worse cognitive outcome [61]. 
Regarding animal experiments, electrical stimulation induced self- 
sustaining status epilepticus (SSSE) was completely suppressed, when 
animals were cooled to 20 ◦C using ice packs only (Fig. 1). This effect 
was sustainable after rewarming with no mortality or discernible 
morbidity [67]. 
In another experiment, researchers induced status epilepticus by 
electrical stimulation using implanted electrodes in the perforant paths 
of rats to show the anticonvulsant effects of hypothermia. Treatments 
included external systemic cooling for 3 h (temperature minimum was 
29 ◦C), administration of diazepam or both. The severity of motor sei-
zures and frequency and amplitude of spontaneous seizure discharges 
were compared among the groups. In diazepam treated animals, seizure 
activity didn’t reduce, except for the later stages of motor seizures and 
only a slight decrease in the amplitude of the discharges was observed. 
Cooling only significantly reduced discharges without affecting the EEG 
discharges. Animals treated with both cooling and low-dose diazepam 
showed a significant drop in frequency and amplitude of EEG discharges 
[68]. 
General hypothermia can also be induced by infusing chilled saline 
into the vasculature. In one example, 4 patients with intractable status 
epilepticus underwent vascular cooling to 31 ◦C–35 ◦C. Despite being on 
intravenous drug therapy that could not address their seizure severity, 
the application of this modest cooling dramatically reduced seizures in 
all 4 patients. However, some adverse effect occurred including shiv-
ering and two patients died. The deaths were not directly related to 
cooling, but hypothermia may have contributed to a fatal sepsis in one 
patient [55]. 
Legriel et al. also perfomed vascular cooling for 24 h reaching core 
body temperatures between 32 ◦C and 34 ◦C. They recruited 270 criti-
cally ill patients with convulsive status epilepticus and randomly 
assigned them to standard care or standard care with hypothermia. They 
found no significant improvements in 90-day functional outcomes 
associated with hypothermia added to standard care, and adverse effects 
were more frequent in the hypothermia group [69]. 
Besides the beneficial effects of systemic hypothermia on neurologic 
function, whole body cooling also carries the risk of infection, coagul-
opathy and cardiopulmonary compromise. These in addition to the risks 
of rewarming set back the clinical utility of systemic therapeutic hypo-
thermia, suggesting that localized cooling may be a better approach in 
treating neurologic diseases [70,71]. 
Table 2 
Comparison of the various cooling methods in terms of temperature reduction, cooling time, area and effect on epileptic conditions.  
Principle Organism Cooling parameters Cooling effect Reference 
General hypothermia 
human 35− 31 ◦C core temp. for 24 h. Dramatic reduction in seizures, two of four remained seizure free 
after rewarming. 
[55] 
rat 28 ◦C and 23 ◦C core temp., each for 30 min. 
50 % reduction of ictal discharges at 28 ◦C, nearly abolished 




Focal temp. reduced by 12.2 ◦C, core temp. by 1.7 ◦C for 
1 h, once a week. 
Weekly seizures decreased from 2.7 to 1.7 events [62] 
Chilled saline 
irrigation 
human Cortex irrigation for 30 s. Cessation of spiking for 6 min. [59] 
Passive focal cooling rat Focal temp. reduced by 2 ◦C for 5.5 weeks Ictal activity abolished for ten weeks after cooling cessation [63] 
Peltier-effect 
human 15 ◦C focal temp. for 30 min. Reduced ECoG power, Glu and GABA concentrations [57,58] 
rat 25− 10 ◦C focal temp. 
EDs were completely attenuated at 15 ◦C along with sensorimotor 
function deterioration [64] 
Liquid coolant 
human Focal temp. reduced by 0.6− 2 ◦C for 5 min. – [65] 
rat 27 ◦C and 24 ◦C focal temp. Both reduced seizure score and after discharge duration [66]  
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4.2. External head cooling 
Researchers report on the trial of a cooling helmet or cap to induce 
brain hypothermia in volunteers and patients with stroke, head injury or 
medically refractory epilepsy. The non-invasive device features a head/ 
neck liner made of a lightweight, thin, flexible, laminated nylon ure-
thane fabric and a conditioning unit (temperature control, liquid pump 
and pressure control, air pump). 
In one case, brain temperatures were continuously monitored for a 
mean of 48–72 h. Warming blankets were used to maintain a core 
temperatures at safe levels. Temperature data of a Neurotrend sensor 
(0.8 cm below the cortical surface) was compared with the patients’ 
bladder (core) temperatures. Brain temperature reduction of 1.84 ◦C 
(range 0.9–2.4 ◦C) was observed within 1 h of helmet application 
(Fig. 2). It took 3.4 h (range 2–6 h) to achieve a brain temperature lower 
than 34 ◦C, and 6.67 h (range 1–12 h) before systemic hypothermia 
(<36 ◦C) occurred. Use of the helmet resulted in no significant com-
plications. A mean 0.63 ◦C/hour (range 0.15–1.45 ◦C/hour) passive 
rewarming rate was observed [72]. 
With the same construct, the lowest temperature that the cooling 
device can produce was used. Volunteers had 30 and 60 min long 
cooling sessions, 3 days separately. Patients had four 60 min long ses-
sions, once a week. Shivering was prevented by keeping the torso warm 
during cooling. Temperature measurements were taken every 5 min. 
Tympanic and intestinal measurements (temperature sensor pill, swal-
lowed by subjects) served as core temperatures. External sensors were 
placed at multiple sites. Seizure counts over 4-week precooling, treat-
ment and follow-up phases were compared. At the end of 60 min of 
cooling, scalp temperature fell by 12.2 ◦C, tympanic temperature by 
1.67 ◦C (both significant), and intestinal temperature by 0.12 ◦C (not 
significant). There were no changes in the patients’ physical examina-
tion after cooling. Average weekly seizure frequency significantly 
decreased from 2.7 to 1.7 events per patient per week [62]. 
A cooling cap and neckband was utilized in a larger trial among 90 
patients with traumatic brain injury. The use of the cooling cap circu-
lating 4 ◦C water in it was an addition to standard TBI care in half of the 
patients. With the cooling cap, mildly hypothermic parenchymal tem-
peratures of 33− 35 ◦C was achieved after four hours of cooling per day 
for three days. The cooling group had a significantly lower intracranial 
pressure 24, 48 and 72 h after injury, than the control group. There were 
no major differences in adverse outcomes [8]. 
A forced air-cooling helmet was used in an animal trial, for 16 
anesthetized dogs. Wass et al. found an average drop of 0.5 ◦C in 
intraparenchymal temperature at a depth of 2 cm with 2 ◦C being the 
biggest reduction [73]. 
To sum up the experiences in head cooling, this method is nonin-
vasive, yet offers local cooling. Its beneficial effects on seizure frequency 
may last for weeks post treatment. However, the area to be cooled 
cannot be specified, and not as focal as invasive methods. Brain tissue is 
only slightly cooled despite using the maximum capacity of the devices. 
Some torso warming must be used to counteract the systemic effects of 
cooling, which might cause discomfort in the long run. 
4.3. Chilled saline irrigation 
Irrigating the exposed brain surface with ice cold saline is a wide-
spread method used by neurosurgeons during operations. The lowered 
cortical temperature terminates paroxysmal discharges as confirmed by 
studies of human brain cooling during operative neurosurgical mapping 
[74]. In these cases, the application of iced saline to the neocortex 
abruptly terminated focal spiking (Fig. 3). Cortical stimulation mapping 
potentially induces focal seizure activity that can be rapidly halted by 
Fig. 1. After 60 min of cooling discharge frequency is significantly decreased and by reaching target temperature of 20 ◦C, SSSE is completely terminated. Spon-
taneous discharges do not reoccur upon rewarming [67]. 
Fig. 2. Brain and core temperatures during cooling and rewarming [72].  
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irrigating the brain surface with cold Ringer’s solution [75]. 
The effect of cold saline cooling on epileptiform discharges was 
investigated in a 41 year-old human patient with focal seizures. Cold 
saline at 4 ◦C was applied to the interictal spike focus for 30 s, and its 
effect on the epileptiform discharges was observed. Cortical stimulation 
was performed after cooling along with ECoG before resection of a right 
frontal tumor. Application of cold saline to the spike focus resulted in a 
transient, complete cessation of spiking for 6 min, while the motor 
threshold for electrical stimulation remained unchanged [59]. 
Ablah et al. aimed to determine if applying chilled solution to the 
exposed cerebral cortex can reduce interictal epileptiform activities in 
12 patients undergoing cortical mapping and resection surgery. They 
applied 150 cm3 of chilled (4 ◦C) or room temperature normal saline 
solution to the cortex. Interictal spikes were counted at baseline and 
compared with spikes after applying saline solutions. Chilled saline 
reduced the number of interictal spikes from 11.46 to 4.87 spikes per 
minute, while room temperature saline had no significant effect on the 
epileptic spike frequency [76]. 
In an animal study of a porcine model, epidural temperatures of 13 
◦C, subdural temperatures of 19 ◦C and parenchymal temperatures of 28 
◦C were achieved by continuous epidural irrigation with chilled saline 
administered via burr holes. After five minutes of irrigation, local hy-
pothermia took place and it was maintained for 6 h without difficulty 
[77]. 
Chilled saline irrigation is the most practical and immediate inter-
vention during surgery. Rapid and effective local cooling is achieved, 
although cooled area and degree of cooling cannot be controlled. It is not 
suitable for long term solutions for epilepsy patients, because the effects 
are temporal - lasting for minutes - even when cooling induced changes 
outlast the application of chilled liquid. 
4.4. Passive focal cooling 
A cooling device can be as simple as a metal plate in contact with the 
brain surface that aids in dissipating the heat from the tissue, thereby 
achieving focal cooling. 
In the study of D’Ambroso et al., the effect of passive focal cooling on 
the development of neocortical epileptic seizures after head injury in the 
rat was studied. ECoG headsets were equipped with metal plates for 
calibrated passive heat dissipation and placed on the exposed cortex for 
several weeks post-injury. Electrical activity was monitored by 5-elec-
trode video-electrocorticography 2–16 weeks post-injury. Cooling by 
0.5–2 ◦C inhibited the onset of epileptic seizures. Cooling by 2 ◦C for 5.5 
weeks beginning 3 days after injury virtually abolished ictal activity. 
This effect persisted over ten weeks after cessation of cooling. This study 
suggests a potential for hypothermia to not only act as an anti- 
convulsant but also to block epileptogenesis [63]. 
Even though the temperature reduction in the above study proved to 
be adequate to inhibit epileptic seizures, the degree of cooling possible 
with passive heat dissipation is only very slight and uncontrolled. Also, 
passive focal cooling cannot differentiate between normal brain states 
and seizures, preventing targeted intervention in patients with epilepsy. 
4.5. Thermoelectric devices 
Thermoelectric devices use Peltier’s 1834 observation that a tem-
perature gradient develops at the junction between two dissimilar con-
ductors when an electric current is applied across them. Thermoelectric 
devices are composed of arrays of crystalline semiconductors sand-
wiched between metallized ceramic plates to create a wafer. One of the 
plates is rapidly cooled while the other is heated by current flowing 
through them. The hot side should be connected to a heat sink to ensure 
effective cooling (Fig. 4). Modern Peltier devices are only a few milli-
meters in length and width and about 1.5 mm thick and are typically 
made of alloys of bismuth, tellurium, selenium, and antimony [78]. 
Peltier devices are widely used tools in animal studies to induce focal 
cooling in a specific area of the brain. An array of such devices can be 
fabricated permitting adjacent areas to be cooled independently or 
simultaneously, as demonstrated by Reed et al. in 1978. Awake cebus 
monkeys and anesthetized cats were used for the experiment. An array 
of 12 small Peltier modules of 4 mm x 4 mm x 2.5 mm was fabricated, 
through which heat could be individually removed or applied to restrict 
cooling to a desired region. A copper baseplate for the Peltier modules 
was shaped to fit the curvature of the area to be implanted. A copper 
pipe for circulation of cold water was soldered to the upper surface of the 
baseplate to function as a heat-sink. For measurements in anesthetized 
cats the module was cooled to 1 ◦C and temperature was measured 
several distances from the device. 30 min long cooling trials were per-
formed during chronic implantation in monkeys. Temperature change 
underneath one module was approximately 8 ◦C. The addition of a 
second module also cooled to 1 ◦C at a distance 2 mm from the first 
caused the 20 ◦C isotherm to shift from a maximum depth of 1.5 mm–2.3 
mm. Cooling the sensorimotor cortex produced postural and behavioral 
deficits in the contralateral arm of one test monkey. Deficits appeared 
within the first few minutes of the 30 min long cooling trial and persisted 
for 30− 60 min following termination of cooling [79]. 
The first study to investigate the ability of thermoelectric devices to 
abort 4-aminopyridine–induced ictal activity was carried out using 
hippocampal slices. The slices were placed on the surface of a Peltier 
module attached to the base of a perfusion chamber. Seizures were 
terminated in 8 s in slices cooled to 21 ◦C, whereas in the control slices, 
ictal events lasted 35 s. The authors also developed a thresholding al-
gorithm, that automatically detected seizures and triggered cooling. 
They observed that cooling terminated seizures only when the thermo-
electric device was in direct contact with the slices, so the effect was not 
attributed to the electrical field generated by the unit [17]. 
One study described the design, optimization and implementation of 
a lightweight Peltier thermoelectric device for modulating temperature 
in brain structures of zebra finch songbirds. The authors provided a 
detailed mathematical description of heat transfer and temperature 
changes in the Peltier device. The device performance was optimized 
based on the derived equations using the construction parameters: 
semiconductor geometry, number of semiconductor junctions, heat 
sinking options and probe dimensions. Two types of miniature devices 
were fabricated. One device was used for cooling a superficial region 
(nucleus HVC, located between 100 μm and 600 μm of the brain surface) 
and thus uses a plate positioned over HVC. The other device was used for 
cooling nucleus LMAN (lateral magnocellular nucleus of the anterior 
nidopallium), which is located 2 mm deep in the brain and was cooled 
by inserting a thin cylindrical wire into the nucleus. Both devices had a 
convective heat sink made of 8 mm long copper wire mesh and a body 
coupled heat sink made of silver sheet. The amount of current passing 
Fig. 3. Electrical after-discharge terminates within seconds after the applica-
tion of cold Ringer’s lactate to the cortex, signified by the arrow. Redrawn 
based on [75]. 
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through the devices was changed every 100 s decreasing from 1 A to -2.5 
A in 0.5 steps. After a change in current, temperatures reached steady 
state in 10–20 s. Maximum amount of cooling at the HVC device plate 
was 10 ◦C at -1.5 A current, at the HVC center cooling was 7 ◦C. For the 
LMAN device, maximum cooling at the plate was 15 ◦C at -1.5 A, at the 
probe tip 11 ◦C, and 4 ◦C 500 μm from probe surface [80]. 
A Peltier chip is also suitable for cooling deeper structures, such as 
the hippocampus (Fig. 5). In anesthetized rats, the inhibitory effect of 
cooling on experimental hippocampal seizures was investigated. A 6 mm 
x 6 mm x 2 mm Peltier chip was used for cooling with a copper plate and 
a 6 mm long silicone coated copper needle attached to it. A copper heat 
sink with water channel circulating 4 ◦C water and a thermometer was 
attached. The cooling needle, a thermocouple, and a needle electrode 
were inserted into the left hippocampus at a depth of 4 mm, and kainic 
acid was injected into the right hippocampus to provoke EDs. Temper-
ature dropped at the needle tip from 33.1 ± 0.7 ◦C to 14.5 ± 1.3 ◦C, 
below 20 ◦C within a 1.6 mm radius, and below 25 ◦C within a 2.4 mm 
radius from the cooling center. The needle tip temperature decreased 
below 20 ◦C within 1 min. The amplitude of EDs was suppressed to 68.1 
± 4.8 % of the precooling value. No histological damage was observed 
[81]. 
The cooling effect seems to be localized to just a small region of 
neocortex in proximity of the cooling device. With a small thermocouple 
inserted into a 30-guage needle, the cortex was mapped below the 
thermoelectric device showing that cooling extends only approximately 
4 mm below the surface [82]. 
Yang et al. explored focal cooling with a thermoelectric device in 
anesthetized rats as a potential therapy for neocortical epilepsy. Artifi-
cial cerebrospinal fluid containing 4-aminopyridine (4-AP) was injected 
to provoke EDs, then focal cooling was applied to the cortex with a 
Peltier device. Within 30 min of 4-AP injection, animals developed 
recurrent seizures lasting 85.7 ± 26.2 s that persisted for 2 h. Cooling to 
20–25 ◦C at seizure onset reduced the seizure duration to 8.4 ± 5.0 s. 
There was no effect on seizure duration when the Peltier device was not 
allowed to make physical contact with the brain (Fig. 6). The duration of 
seizures remained reduced even after rewarming from prior cooling. 
Histopathologic examination of these animals has not revealed any ab-
normalities after 2 h long exposure to as low as 5 ◦C. There was no 
neuronal loss or activation of apoptotic pathways, and dendritic beading 
and spine loss were reversible [83]. 
The same group observed that the threshold temperature required 
for any reduction in seizure duration was 24 ◦C. A sharp temperature 
gradient developed across the cooled neocortex: 31 ◦C at 4 mm below 
the Peltier, which was cooled to the lowest temperature of 20 ◦C [84]. 
Regarding threshold temperature, different results were gained by a 
study group investigating a Peltier chip in rats having epileptic dis-
charges induced by kainic acid injection in the neocortex. The Peltier 
chip was attached to a heat sink with a water channel. Two silicon tubes 
were connected to the heat sink, and water at 37 ◦C was circulated in the 
channel. The epileptic cortex was cooled to 30 ◦C, 28 ◦C and 25 ◦C. 
Within 30 s, brain surface temperature decreased to 14.8 ± 1.5 ◦C and at 
2 mm depth temperature decreased to 27.1 ± 3.1 ◦C. Epileptic activity 
started to decrease immediately after cooling started. Cooling to 30 ◦C, 
Fig. 4. A Peltier device with heat sink: (a) Front and side view of a typical Peltier cell; (b) Dimensions of an attached aluminum heat sink; (c) Schematics of the 
current flow through the cell [4]. 
Fig. 5. Thermoelectric chip for cooling the hippocampus [81].  
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28 ◦C and 25 ◦C resulted in a gradual activity reduction and complete 
cessation at 25 ◦C. The temperature of the hot side of the chip was 
maintained at approximately 36.9 ◦C [85]. 
A possible lower limit for the therapeutic temperature was described 
by Fuji et al. upon investigating focal cooling on penicillin G induced 
epileptic seizures in a freely-moving rat. They used a PID-controlled 
Peltier device chronically implanted on the epileptic focus. Cooling to 
20 ◦C, 15 ◦C, and 10 ◦C was performed, while monitoring seizure fre-
quency and neurologic changes. Cooling down from 20 ◦C to 15 ◦C 
significantly improved both seizure frequency and neurologic functions. 
Cooling to 10 ◦C also suppressed seizures, but with no further 
improvement in neurologic function. Subsequent investigation of 
sensorimotor function revealed significant deterioration in foot-fault 
tests and the receptive field size at 15 ◦C, suggesting that this temper-
ature may be the safety limit [86]. 
Investigating local hypothermia in the same temperature range, Kida 
et al. also noted, that different frequency ranges were sensitive to 
particular temperatures, that is, 25 ◦C, 20 ◦C, and 15 ◦C attenuated beta, 
alpha to beta, and delta to beta frequency discharges, respectively [64]. 
A low temperature limit also exists for irreversible histological 
change and motor dysfunction. Oku and colleagues performed cooling to 
20 ◦C, 15 ◦C, 10 ◦C, 5 ◦C, 0 ◦C, and − 5 ◦C for 1 h using a 6 mm x 6 mm x 2 
mm thermoelectric chip placed on the sensorimotor cortex of anes-
thetized rats. Natural rewarming was allowed thereafter. Motor function 
was evaluated using the beam-walking scale (BWS) every day for 7 days 
after cooling. Temperature values in the cooled groups of 5.0 ◦C, 0.0 ◦C 
and -5.0 ◦C were at 1 mm depth 8.4 ◦C, 7.0 ◦C and 3.9 ◦C, at 3 mm depth 
18.0 ◦C, 17.6 ◦C and 14.8 ◦C, respectively. BWS score decreased in the -5 
◦C group on the day after cooling, other temperature groups were not 
affected. Histologically, cryo-injury was observed only in the -5 ◦C 
group. Focal cooling of the cortex for 1 h above the temperature of 0 ◦C 
did not induce any irreversible histological change or motor dysfunction 
[87]. 
Cooling itself may not be responsible for any additional foreign body 
response. Although there is minimal gliosis close to the region of cortical 
contact with the Peltier, it is similar to the response provoked by any 
foreign body and cannot be attributed to cooling [88]. In vivo experi-
ments in rats and cats using Peltier device lasting 10 months long 
resulted in minimal gliosis near the area of cortical contact with the 
device, which changes were also seen in sham-operated rat cortex [82]. 
The effect of cooling can be evaluated through nociceptive pain tests. 
In one case hot plate tests and thermal withdrawal tests at 52 ◦C were 
conducted, latency in escape behavior was measured in restrained, 
awake rats. The cooling component was a 6 mm x 6 mm, PID-controlled 
Peltier chip, with an attached thermocouple probe and a copper heat 
sink. Heat was transferred via 5 ◦C Ringer’s solution. Brain surface 
temperature was controlled and cooled to 20 ◦C, 15 ◦C and 10 ◦C. In the 
thermal withdrawal tests, 20 ◦C cooling resulted no latency in escape 
behaviour, however, significant latency occurred at 15 ◦C. Histological 
examination showed no neuronal damage after 2 weeks of implantation. 
This study showed, for the first time, that focal cooling of the sensori-
motor cortex at 15 ◦C was able to suppress nociceptive pain with a 
minimal influence on sensorimotor functions [89]. 
It should be noted that experimental epilepsies in rat models typi-
cally result in 60–80 s long seizures every 2− 3 min, which is an unre-
alistically high frequency for almost all human epilepsies. This suggests 
that induced focal seizures in rodents would require a much larger 
temperature reduction than epileptic seizures in humans, meaning that 
in human cases the current to power the device and the amount of heat 
that needs to be dissipated would possibly be lower, too, since these are 
directly linked to the necessary degree of cooling [82]. 
Thermoelectric cooling is possibly the most extensively researched 
approach to focal cooling. It offers specific, targeted cooling of selected 
brain areas, whether it is a superficial or a deeper structure. Most Peltier 
devices used in animal studies are very similar in size, performance and 
construction materials, which makes the results easily comparable. The 
possible degree of cooling is large enough to reach temperatures that 
also inhibit normal neural functions so a safety limit can be established 
while ensuring maximum cooling efficiency at the same time to cancel 
epileptic discharges. A major downside to this method is the inevitable 
activation of astroglial cells at sites close to or in contact with the device. 
Although cooling does not induce additional astrogliosis on top of the 
normal foreign body response, this phenomenon can hinder the per-
formance of devices equipped with additional sensors, such as temper-
ature measurement or EEG. 
4.6. Liquid coolant 
Similarly to irrigation with iced saline, focal cooling devices can 
utilize some sort of liquid as their cooling medium. In most cases, a metal 
tubing shaped as a loop or a coil serves as the cooling surface through 
which chilled saline, ethanol or methanol is circulated. Usually, the 
degree of cooling is manipulated through the adjustment of the liquid 
flow rate that allows for precise target temperature control. In vitro 
studies with brain slices are also conducted in this manner, in this case, 
the chilled perfusate itself functions as the cooling medium. 
In experiments with rat brain slices exposed to 4-AP, 4-AP plus 
bicuculline, and Mg2+-free artificial cerebrospinal fluid (aCSF), field 
excitatory synaptic potentials as well as spontaneous epileptiform ac-
tivity were consistently aborted, when the aCSF was cooled to 28–34 ◦C. 
By adjusting the flow rate of cold aCSF, slow and rapid cooling para-
digms were studied, both of which completely, but reversibly, aborted 
epileptiform discharges. Interestingly, only a slight temperature drop of 
1–2 ◦C was needed to terminate the discharges with rapid cooling, while 
cooling slower gradually decreased the amplitude of EDs, requiring a 
much longer time before complete cessation. Slow cooling reduced 
discharge frequency by 90 % at absolute temperature drops to 21–23 ◦C 
and completely terminated them at 14–15 ◦C. Hypothermia seemed safe 
in these models, because slices could tolerate as long as 2 h of cooling at 
temperatures as low as 8 ◦C [90]. 
Slowly cooling the perfusate bathing hippocampal slices from 34 ◦C 
to 20 ◦C can reversibly abolish the rapid gamma oscillations of 
approximately 40 Hz, while preserving normal evoked excitatory syn-
aptic potentials. The observation, that evoked synaptic responses were 
maintained but gamma activity disappeared, suggests that cooling may 
Fig. 6. Examples of 4-AP-induced neocortical seizures: (a) 90 s long control 
seizure; (b) The course of a seizure is unchanged, when the Peltier device is not 
in direct contact with the brain; (c) A seizure is terminated by direct cortical 
cooling within 9 s; (d) and (e) are start and end of the seizure in (c). Signal 
amplitude and time scale are 0.3 mV and 10 s, respectively. Redrawn based 
on [83]. 
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limit paroxysmal activity (EDs) without shutting down normal brain 
electrical activity [91]. 
Using circulation of chilled fluid, Burton et al. studied the effects of 
cooling kindled seizures in awake, freely moving rats. The fabricated 
implant comprised of a pure copper tubing flat coil contacting the dorsal 
brain surface. Cooling to target temperatures of 24 ◦C and 27 ◦C was 
achieved by circulating 8 ◦C and 16 ◦C water, respectively, at a flow rate 
of 10 mL/min. Both target temperatures were reached by 180 s of 
cooling. After discharge duration and seizure score (0–5) were signifi-
cantly reduced compared to controls, but no significant difference was 
found between the two cooled groups for these parameters [66]. 
A microfluidic device, termed the cooling chip was fabricated by 
Cooke and colleagues for reversible deactivation of the neocortex to 
examine its functional macro-circuitry, behavioral and cortical plasticity 
in rodents, ferrets and primates (Fig. 7). The device, termed the cooling 
chip consisted of a thin silicone tubing (through which chilled ethanol 
was circulated) embedded in mechanically compliant poly-
dimethylsiloxane (PDMS). PDMS was tailored to compact device di-
mensions (as small as 21 mm3), MR compatibility was ensured due to the 
absence of metal parts. The device was shaped to two different forms: a 
gyral design for contacting the brain surface, and a sulcal design for 
insertion into a sulcus. The silicone tubing for the gyral design was 
shaped as a coil embedded in PDMS, the sulcal design tubing was 
forming a loop with variable length to be able to cool deeper sulcii. After 
implantation, localized cortical temperature drop from 37 ◦C to 20 ◦C 
could be achieved in less than 3 min and target temperature could be 
maintained indefinitely. Cooling to 20 ◦C and below abolished sensory 
activity in the species investigated and spontaneous activity was 
frequently aborted too [92]. 
An earlier construct was the so-called cryoloop developed by Lomber 
et al. The device consisted of straight 23 gauge hypodermic stainless 
steel tubing and cooling was effected by passing chilled methanol 
through its lumen. The circulated methanol was cooled by passing it 
through a bath of methanol and dry ice pellets reaching a temperature as 
low as − 75 ◦C. The cryoloops were implanted in cats and monkeys and 
were maintained there for periods in excess of 2 years. Even for this long 
duration, researchers observed no structural, metabolic of functional 
changes in the deactivated tissue, and full reversibility of cooling- 
induced effects was maintained. Cooling the cryoloop and cortex from 
38 ◦C to 8 ◦C silenced visually evoked activity in vigorously responding 
neurons. During cooling of cryoloops to even 0 ◦C afferent axons 
remained active and 20 ◦C was identified as the critical temperature 
below which neurons fail to be activated. Temperatures above 24 ◦C 
showed little diminution in evoked activity. There is a very steep 
gradient between 24 ◦C and 20 ◦C along which activity progressively 
decreases. Effect of the cooling was restricted to 1.5–2.5 mm distance 
from the cryoloop even when cryoloop temperature was reduced to 1 ◦C. 
Positions 2 mm distant from the cryoloop are cooled only slightly, and 
positions 5.6 mm distant are completely unaffected by the cooling. 
Cortical tissue adjacent to the cryoloop reaches a deactivating temper-
ature of 20 ◦C within 10 s. For deep cortical layers at 1.3 mm, the 
deactivating temperature lags by approximately 1− 2 min. 2− 3 min is 
required for temperatures at all distances from the cryoloop to return to 
normal body temperature [93]. 
Coomber et al. induced focal hypothermia in the guinea pig auditory 
cortex with a cooling loop to determine the extent to which reversible 
cooling deactivation spreads throughout the brain. Dry ice cooled 
ethanol was circulated in a 4 mm diameter cooling loop made of a 
stainless steel tube with 0.25 mm lumen diameter. Cortex temperature 
could be manipulated by altering the speed of the pump. Auditory 
“click”-evoked potentials were recorded before cooling, and then at 
progressively lower cooling loop temperatures (20 ◦C, 15 ◦C, 10 ◦C, and 
2 ◦C), and finally after a 20 min recovery period. Cooling the surface of 
auditory cortex to 2 ◦C reduced the temperature in all layers of primary 
auditory cortex below 20 ◦C. Temperature gradients in the cortex 
ranging from 10 ◦C to 20 ◦C up to a depth of 2000 μm were observed. 
Cooling the surface of the cortex to 2 ◦C abolished or significantly 
attenuated auditory-evoked field potentials in all cortical layers [94]. 
The liquid coolant approach was tested in human clinical trials. In one 
study, researchers implanted eighteen patients scheduled to undergo 
surgery for medically intractable epilepsy with a cooling probe. It con-
sisted of a stainless steel chamber infused with chilled saline, cooling the 
device close to, but not below, 0 ◦C (Fig. 8). The thermal gradients 
created under the cooling probe during active cooling were examined 
Fig. 7. Schematic layout of the experimental design for the cooling chip. Redrawn based on [92].  
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along with the effects of cooling on spontaneous and stimulus-evoked 
local EEG activity. Also, critical sites of language in the left frontal 
lobe were cooled in two patients. In all cases it was possible to cool the 
chamber temperature to between 0 ◦C and 3 ◦C. Temperatures that 
disrupt local synaptic activity (below 20 ◦C) were achieved throughout 
the gray matter directly below the cooling probe (<4 mm thickness). 
Tissue temperatures at brain sites farther than 6 mm from the probe 
surface do not reach this threshold. In the verbal counting task, when the 
temperature of the cooling probe chamber had been decreased and 
maintained within a range of 1 ◦C–3 ◦C, both patients demonstrated 
qualitatively similar speech dysfunction. Following rewarming, both 
patients performed the counting task in a normal fashion [94]. 
An active cooling device using chilled liquid can be fabricated from a 
standard ECoG grid (Fig. 9). Smyth et al. integrated a custom made 
liquid cooling system circulating 4 ◦C saline on an ECoG grid to examine 
the thermal characteristics of canine and human brain. The grid was 
made in two sizes: 4cm × 4cm = 1600 mm2 and 2cm × 4cm = 800 mm2 
for humans and dogs, respectively. Cooling experiments took place 
before the resection of a neocortical epileptogenic focus in human 
patients. Dogs were implanted with perfused grids and actively cooled 
for 2 h. Cooling of 0.6–2 ◦C was achieved both actively and passively to a 
depth of 10–15 mm from the cortical surface. A stable 14-18 ◦C decrease 
in temperature was measured in dogs after closing the craniotomy, 
however, no effect on brain activity was observed [65]. 
Circulating chilled liquid can result in temperature drops similar to 
that of a Peltier device, depending on the coolant used. Geometries and 
size of these devices are much more easily tailored. This might also be a 
downside regarding the comparability of the results. Because the liquid 
needs continuous refrigeration and circulation, some additional equip-
ment is necessary, such as cooling reservoirs and pumps, making it less 
mobile than a Peltier device. However, cooling with liquid does not need 
any heat sinks, that are a must for thermoelectric cooling. 
5. Conclusion 
Therapeutic hypothermia has various applications, in both systemic 
and focal ways. Its beneficial effects in a number of neurologic diseases 
have been researched and recognized for over several decades. 
Historically, general or systemic cooling was studied first in humans 
with disorders such as epilepsy or TBI, and it remained in clinical 
practice to aid in treating patients suffering from hypoxic ischemic en-
cephalopathy or post cardiac arrest. Systemic hypothermia is however 
not well suited for epilepsy treatment, because the prolonged cooling 
required could raise risks of cardiopulmonary compromise and other 
side effects. 
Localized cooling is much more researched recently as it offers 
important advantages over systemic hypothermia: cooling affects only 
the targeted area, temperature reductions can exceed that of reached 
with systemic cooling, generalized side effects are avoided, devices used 
are much smaller and practical and are easier to control. 
Among these, the Peltier device and cooled fluid circulating devices 
are the most promising approaches. Both offer significant temperature 
reduction in the brain tissue and exert their effects only focally. 
Numerous studies show that these devices are highly effective in 
reducing the amplitude of epileptic discharges and terminating ongoing 
seizures while preserving normal brain activity, though inactivating 
temperatures of 15 ◦C or below are readily reached, too. A Peltier device 
seems more adequate to long term implantation, as it needs fewer ac-
cessories than a liquid circulating implant. 
However, long-term clinical application of such devices needs to be 
considered with extra care regarding the materials used for contacting 
the human brain. Biocompatibility must be ensured by encapsulation of 
device surfaces. Good candidates for soft encapsulation are silicon, 
Fig. 8. Design of the cooling chamber for human trials: (a) The arrows show 
the direction of saline inflow and outflow, there are separate thermocouples for 
chamber and parenchymal temperature measurement; (b) The probe from 
below indicating the two silver contacts spaced 5 mm apart [94]. 
Fig. 9. The sterile cooling grid for measurements in humans with temperature probes [65].  
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polyimides, liquid crystal polymers, to name a few [96]. Ethical ques-
tions of long-term brain machine interfaces should also be clarified 
before the translational potential of these cooling devices could be 
realized. 
Another obstacle to overcome in the future is the induced foreign 
body response by implanted devices, which is rather related to the de-
vice itself, and not cooling effect it exerts on the nearby tissue. 
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hypothermia for 359 operations to clip cerebral aneurysms. Br J Anaesth 2004;93: 
343–7. https://doi.org/10.1093/bja/aeh206. 
[22] Yang XF, Ouyang Y, Kennedy BR, Rothman SM. Cooling blocks rat hippocampal 
neurotransmission by a presynaptic mechanism: Observation using 2-photon 
microscopy. J Physiol (Paris) 2005;567:215–24. https://doi.org/10.1113/ 
jphysiol.2005.088948. 
[23] Rossetti AO. What is the value of hypothermia in acute neurologic diseases and 
status epilepticus? Epilepsia 2011;52(Suppl 8):64–6. https://doi.org/10.1111/ 
j.1528-1167.2011.03241.x. 
[24] Andersen P, Gjerstad L, Pasztor E. Effect of cooling on synaptic transmission 
through the cuneate nucleus. Acta Physiol Scand 1972;84:433–47. https://doi.org/ 
10.1111/j.1748-1716.1972.tb05194.x. 
[25] Andersen P, Gjerstad L, Pasztor E. Effects of cooling on inhibitory processes in the 
cuneate nucleus. Acta Physiol Scand 1972;84:448–61. https://doi.org/10.1111/ 
j.1748-1716.1972.tb05195.x. 
[26] Shen KF, Schwartzkroin PA. Effects of temperature alterations on population and 
cellular activities in hippocampal slices from mature and immature rabbit. Brain 
Res 1988;475:305–16. https://doi.org/10.1016/0006-8993(88)90619-1. 
[27] Pásztor E, Kukorelli T. Effect on cortical evoked potentials of local ooling of the 
cerebral surface. Acta Physiol Acad Sci Hung 1967;31:41–50. 
[28] Volgushev M, Vidyasagar TR, Chistiakova M, Yousef T, Eysel UT. Membrane 
properties and spike generation in rat visual cortical cells during reversible cooling. 
J Physiol 2000;522:59–76. https://doi.org/10.1111/j.1469-7793.2000.0059m.x. 
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